Ad is loading...
IEMKX
Price
$9.86
Change
-$0.02 (-0.20%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

IEMKX vs RNWFX

Header iconIEMKX vs RNWFX Comparison
Open Charts IEMKX vs RNWFXBanner chart's image
Voya Multi-Manager Emerging Markets Eq R
Price$9.86
Change-$0.02 (-0.20%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
IEMKX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IEMKX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IEMKX is a Sell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. IEMKX (197M). RNWFX pays higher dividends than IEMKX: RNWFX (1.51) vs IEMKX (1.40). IEMKX was incepted earlier than RNWFX: IEMKX (13 years) vs RNWFX (23 years). IEMKX is a more actively managed with annual turnover of: 85.00 vs. RNWFX (32.00). IEMKX has a lower initial minimum investment than RNWFX: IEMKX (0) vs RNWFX (250). RNWFX annual gain was more profitable for investors over the last year : 11.54 vs. IEMKX (8.12). RNWFX return over 5 years is better than : 17.17 vs. IEMKX (-14.28).
IEMKXRNWFXIEMKX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years23 years-
Gain YTD1.9657.09928%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets197M60.9B0%
Annual Yield % from dividends1.401.5193%
Returns for 1 year8.1211.5470%
Returns for 3 years-27.89-14.55192%
Returns for 5 years-14.2817.17-83%
Returns for 10 years-1.8541.00-5%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics